The smallpox vaccine induces an early neutralizing IgM response

Vaccine

Volumn 28, Issue 1, 2009, Pages 140-147

  Moyron Quiroz, Juan E ^a   McCausland, Megan M ^a   Kageyama, Robin ^a   Sette, Alessandro ^a   Crotty, Shane ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

IgM; Neutralizing antibodies; Smallpox vaccine; Vaccinia virus

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; PEPTIDE; SMALLPOX VACCINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; C57BL 6 MOUSE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNIZATION; INFECTION CONTROL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SMALLPOX; VACCINATION; VACCINIA VIRUS; VIRION; VIRUS INFECTION;

ADULT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; FEMALE; HELA CELLS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEUTRALIZATION TESTS; PROTEIN ARRAY ANALYSIS; SMALLPOX; SMALLPOX VACCINE; VERO CELLS; YOUNG ADULT;

EID: 70749155621     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.086     Document Type: Article

References (57)

1. Amanna I.J., Slifka M.K., and Crotty S. Immunity and immunological memory following smallpox vaccination. Immunol Rev 211 June (2006) 320-337
2. Pütz M.M., Alberini I., Midgley C.M., Manini I., Montomoli E., and Smith G.L. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol 86 November (Pt 11) (2005) 2955-2960
3. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., and Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 November (10) (2003) 4969-4973
4. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 9 September (9) (2003) 1131-1137
5. Taub D.D., Ershler W.B., Janowski M., Artz A., Key M.L., McKelvey J., et al. Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med 121 December (12) (2008) 1058-1064
6. Xu R., Johnson A.J., Liggitt D., and Bevan M.J. Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172 May (10) (2004) 6265-6271
7. Fischer M.A., and Norbury C.C. Initiation of primary anti-vaccinia virus immunity in vivo. Immunol Res 37 2 (2007) 113-133
8. Panchanathan V., Chaudhri G., and Karupiah G. Correlates of protective immunity in poxvirus infection: where does antibody stand?. Immunol Cell Biol 86 January (1) (2008) 80-86
9. Fang M., and Sigal L.J. Antibodies CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J Immunol 175 November (10) (2005) 6829-6836
10. Chaudhri G., Panchanathan V., Bluethmann H., and Karupiah G. Obligatory requirement for antibody in recovery from a primary poxvirus infection. J Virol 80 July (13) (2006) 6339-6344
11. Panchanathan V., Chaudhri G., and Karupiah G. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J Virol 80 July (13) (2006) 6333-6338
12. Chaudhri G., Panchanathan V., Buller R.M., van den Eertwegh A.J., Claassen E., Zhou J., et al. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Proc Natl Acad Sci USA 101 June (24) (2004) 9057-9062
13. Moss B. Poxvirus entry and membrane fusion. Virology 344 January (1) (2006) 48-54
14. Lustig S., Fogg C., Whitbeck J.C., Eisenberg R.J., Cohen G.H., and Moss B. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge. J Virol 79 November (21) (2005) 13454-13462
15. Fogg C.N., Americo J.L., Earl P.L., Resch W., Aldaz-Carroll L., Eisenberg R.J., et al. Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge. J Virol 82 August (16) (2008) 8022-8029
16. Chen Z., Earl P., Americo J., Damon I., Smith S.K., Yu F., et al. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. J Virol 81 September (17) (2007) 8989-8995
17. Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 79 September (18) (2005) 11724-11733
18. Benhnia M.R., McCausland M.M., Moyron J., Laudenslager J., Granger S., Rickert S., et al. Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. J Virol 83 February (3) (2009) 1201-1215
19. Edghill-Smith Y., Golding H., Manischewitz J., King L.R., Scott D., Bray M., et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med 11 July (7) (2005) 740-747
20. Frey S.E., Newman F.K., Yan L., Lottenbach K.R., and Belshe R.B. Response to smallpox vaccine in persons immunized in the distant past. JAMA 289 June (24) (2003) 3295-3299
21. McClain D.J., Harrison S., Yeager C.L., Cruz J., Ennis F.A., Gibbs P., et al. Immunologic responses to vaccinia vaccines administered by different parenteral routes. J Infect Dis 175 April (4) (1997) 756-763
22. Czar M.J., Kersh E.N., Mijares L.A., Lanier G., Lewis J., Yap G., et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc Natl Acad Sci USA 98 June (13) (2001) 7449-7454
23. McCausland M.M., Yusuf I., Tran H., Ono N., Yanagi Y., and Crotty S. SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase. J Immunol 178 January (2) (2007) 817-828
24. Hosono M., and Muramatsu S. Use of 2-mercaptoethanol for distinguishing between IgM and IgG antibody-producing cells of mice immunized with bovine globulin. J Immunol 109 October (4) (1972) 857-863
25. Okuno T., and Kondelis N. Evaluation of dithiothreitol (DTT) for inactivation of IgM antibodies. J Clin Pathol 31 December (12) (1978) 1152-1155
26. Ochsenbein A.F., Pinschewer D.D., Odermatt B., Carroll M.C., Hengartner H., Zinkernagel R.M., and Protective. T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 190 October (8) (1999) 1165-1174
27. Benhnia M.R., McCausland M.M., Su H.P., Singh K., Hoffmann J., Davies D.H., et al. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J Virol 82 April (7) (2008) 3751-3768
28. Newman F.K., Frey S.E., Blevins T.P., Mandava M., Bonifacio A., Yan L., et al. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J Clin Microbiol 41 July (7) (2003) 3154-3157
29. Lustig S., Fogg C., Whitbeck J.C., and Moss B. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement. Virology 328 October (1) (2004) 30-35
30. Davies D.H., Molina D., Wrammert J., Miller J., Hirst S., Mu Y., et al. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7 May (10) (2007) 1678-1686
31. Tsung K., Yim J.H., Marti W., Buller R.M., and Norton J.A. Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol 70 January (1) (1996) 165-171
32. Moutaftsi M., Bui H., Peters B., Sidney J., Salek-Ardakani S., Oseroff C., et al. Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses. J Immunol 178 June (11) (2007) 6814-6820
33. Sette A., Moutaftsi M., Moyron-Quiroz J., McCausland M.M., Davies D.H., Johnston R.J., et al. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 28 June (6) (2008) 847-858
34. Davies D.H., Liang X., Hernandez J.E., Randall A., Hirst S., Mu Y., et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 102 January (3) (2005) 547-552
35. Odegard J.M., Marks B.R., Diplacido L.D., Poholek A.C., Kono D.H., Dong C., et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exper Med November (2008)
36. Okada T., and Cyster J.G. B cell migration and interactions in the early phase of antibody responses. Curr Opin Immunol 18 June (3) (2006) 278-285
37. Schoenberger S.P., and Crotty S. Immunologic memory. Fundam Immunol (2009) 862-897
38. MacLennan I.C. Germinal centers. Annu Rev Immunol 12 (1994) 117-139
39. Crotty S., Kersh E.N., Cannons J., Schwartzberg P.L., and Ahmed R. SAP is required for generating long-term humoral immunity. Nature 421 January (6920) (2003) 282-287
40. Schwartzberg P.L., Mueller K.L., Qi H., and Cannons J.L. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat Rev Immunol 9 January (1) (2009) 39-46
41. Crotty S., McCausland M.M., Aubert R.D., Wherry E.J., and Ahmed R. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. Blood 108 November (9) (2006) 3085-3093
42. Cannons J.L., Yu L.J., Jankovic D., Crotty S., Horai R., Kirby M., et al. SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation. J Exp Med 203 June (6) (2006) 1551-1565
43. Law M., Pütz M.M., and Smith G.L. An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol 86 April (Pt 4) (2005) 991-1000
44. Galmiche M.C., Goenaga J., Wittek R., and Rindisbacher L. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology 254 February (1) (1999) 71-80
45. Fogg C.N., Americo J.L., Lustig S., Huggins J.W., Smith S.K., Damon I., et al. Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges. Vaccine 25 April (15) (2007) 2787-2799
46. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. 1988. Smallpox and its eradication. World Health Organization, Geneva, Switzerland.
47. Hopkins R.J., and Lane J.M. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Clin Infect Dis 39 September (6) (2004) 819-826
48. Kempe C.H., Berge T.O., and England B. Hyperimmune vaccinial gamma globulin. Pediatrics 18 (1956) 177-188
49. Kempe C.H., Bowles C., Meiklejohn G., Berge T.O., St. Vincent L., and Sundara Babu B.V. The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox. Bull World Health Organ 25 (1961) 41-48
50. Marennikova S.S. The use of hyperimmune antivaccinia gamma-globulin for the prevention and treatment of smallpox. Bull World Health Organ 27 (1962) 325-330
51. Hobday T.L. Antivaccinial gamma-globulin in the control of smallpox. Lancet 1 April (1962) 907-908
52. Lawrence S.J., Lottenbach K.R., Newman F.K., Buller R.M., Bellone C.J., Chen J.J., et al. Antibody responses to vaccinia membrane proteins after smallpox vaccination. J Infect Dis 196 July (2) (2007) 220-229
53. Pütz M.M., Midgley C.M., Law M., and Smith G.L. Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Nat Med 12 November (11) (2006) 1310-1315
54. Karem K.L., Reynolds M., Braden Z., Lou G., Bernard N., Patton J., et al. characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol 12 July (7) (2005) 867-872
55. Brilliant L.B., Nakano J.H., Kitamura T., Hodakevic L.N., and Bharucha P.B. Occupationally-acquired smallpox in an IgM-deficient health worker. Bull World Health Organ 59 January (1) (1981) 99-106
56. Chandra R.K., Kaveramma B., and Soothill J.F. Generalised non-progressive vaccinia associated with IgM deficiency. Lancet 1 April (7597) (1969) 687-689
57. Mayumi M., Yamaoka K., Tsutsui T., Mizue H., Doi A., Matsuyama M., et al. Selective immunoglobulin M deficiency associated with disseminated molluscum contagiosum. Eur J Pediatr 145 April (1-2) (1986) 99-103